Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
50.90
+0.80 (1.60%)
At close: Jul 19, 2024, 4:00 PM
50.86
-0.04 (-0.08%)
Pre-market: Jul 22, 2024, 7:26 AM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 111, with a low estimate of 80 and a high estimate of 138. The average target predicts an increase of 118.07% from the current stock price of 50.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VKTX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 8 | 8 | 7 | 7 |
| Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $105 | Buy | Initiates | $105 | +106.29% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +76.82% | Jun 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 | Strong Buy | Maintains | $120 | +135.76% | Jun 17, 2024 |
| Raymond James | Raymond James | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jun 4, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +135.76% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.14
from -0.91
EPS Next Year
-1.58
from -1.14
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 200.7M | 491.4M | 1.1B |
| Avg | n/a | n/a | 30.9M | 127.5M | 480.8M |
| Low | n/a | n/a | n/a | n/a | 57.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,487.9% | 781.9% |
| Avg | - | - | - | 311.9% | 277.3% |
| Low | - | - | - | - | -54.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.89 | -1.01 | -0.35 | 2.27 | 7.46 |
| Avg | -1.14 | -1.58 | -1.61 | -0.63 | 2.17 |
| Low | -1.24 | -2.07 | -2.56 | -3.40 | -1.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.